A carregar...

Sofosbuvir: a novel oral agent for chronic hepatitis C

Major changes have emerged during the last few years in the therapy of patients with chronic hepatitis C (CHC). Several direct acting antiviral agents (DAAs) have been developed showing potent activity against hepatitis C virus (HCV) and incrementally improving the rates of sustained virological res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cholongitas, Evangelos, Papatheodoridis, George V.
Formato: Artigo
Idioma:Inglês
Publicado em: Hellenic Society of Gastroenterology 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4188929/
https://ncbi.nlm.nih.gov/pubmed/25332066
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!